*ST Huicheng faces potential delisting as creditors initiate restructuring process

Today's market saw significant developments, particularly concerning companies facing financial distress and restructuring efforts. Notably, *ST Huicheng Co., Ltd. and *ST Nachuan Co., Ltd. are grappling with severe financial challenges that could lead to delisting.

Earnings & Performance

• Maohua Shihua Co., Ltd. (000637) reported a net loss of 129.62 million yuan for 2023, despite a slight improvement over the previous year. The company cited geopolitical instability and weak demand as key factors affecting its performance.
• Shandong Sinocera Functional Material Co., Ltd. (300285) announced a 16.64% increase in operating revenue to 2.51 billion RMB for H1 2026, with a net profit rise of 9.36% to 362.76 million RMB. A cash dividend of 0.50 RMB per 10 shares is planned.

Deals & Restructuring

• Chongqing Huicheng Co., Ltd. (002168) is undergoing pre-restructuring proceedings initiated by creditor Chongqing Lvfa Asset Management Co., Ltd. The court has yet to formally accept the restructuring application, and if unsuccessful, the company faces delisting.
• *Fujian Nachuan Pipe Technology Co., Ltd. (ST Nachuan Co., Ltd.) (300198) issued its fourth risk warning regarding potential delisting due to negative financials and unresolved risks despite attempts at management restructuring.
• Henan Kaiwang Electronic Technology Co., Ltd. (301182) plans to acquire 51% equity in Dongguan Xingding Hardware Products Co., Ltd. for RMB 285.6 million, aiming to enhance competitiveness in the AI computing sector.
• Beijing Hualian Department Store Co., Ltd. (000882) held an extraordinary general meeting where shareholders approved the dissolution of the company.

Regulatory & Governance

• *ST Lingda Co., Ltd. (300125) announced the revocation of its delisting risk warning, with trading resuming on August 7, 2026.
• *ST Huicheng Co., Ltd. (002168) also released a self-inspection report regarding its restructuring application, highlighting ongoing risks.

Other Notable Developments

• Green Biological Co., Ltd. (301688) received legal opinion approval for its IPO on the ChiNext market, confirming compliance with regulatory requirements.
• Wenzhou Hongfeng Co., Ltd. (300283) plans to issue A-shares to specific targets to raise up to 450 million RMB for production expansion.
• Zhanxin Co., Ltd. (301707) announced its IPO on the ChiNext market, set for August 7, 2026, detailing associated risks for investors.
• Jafron Biomedical Co., Ltd. (300529) reminded investors of the put option for its convertible bonds, exercisable from August 7 to August 13, 2026.

Investors are advised to monitor these developments closely, particularly the restructuring efforts of *ST Huicheng and *ST Nachuan, which could significantly impact their market positions.